Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12620001233910
Ethics application status
Approved
Date submitted
22/09/2020
Date registered
18/11/2020
Date last updated
18/11/2020
Date data sharing statement initially provided
18/11/2020
Type of registration
Retrospectively registered

Titles & IDs
Public title
Tracking surgical site infection post caesarean section through HealthTracker
Scientific title
Tracking surgical site infection post caesarean section through post hospital discharge surveillance
Secondary ID [1] 302341 0
Nil known
Universal Trial Number (UTN)
U1111-1258-3822
Trial acronym
HealthTracker: HealthTracker Surgical Site Infection Surveillance
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Surgical site Infections 319113 0
Caesarean section 319114 0
Condition category
Condition code
Surgery 317074 317074 0 0
Other surgery
Infection 317075 317075 0 0
Studies of infection and infectious agents
Reproductive Health and Childbirth 317404 317404 0 0
Childbirth and postnatal care

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
The HealthTracker SSI surveillance
The women who give a live birth will receive an SMS invitation to complete a wound healing questionnaire via HealthTracker on day 30 of CS. At the end of the questionnaire, they will be asked to completed a feedback survey about the use of HealthTracker. it will take less than 10 minutes to complete both if they choose to complete.
The research team via HealthTracker will send an automated SMS invitation women linking women their unique ID which is generated by using their MRNs.
Uptake and acceptability of the Healthtracker will be monitored by the team through a regular report
Intervention code [1] 318633 0
Early detection / Screening
Comparator / control treatment
Control group: baseline data will be collected from the John Hunter Hospital Patient Management System from 1/October 2010- 31/ May 2020.
Control group
Historical

Outcomes
Primary outcome [1] 325165 0
Rate of patient reported surgical site infections:
SSI rates will be identified from a combination of data sources from HealthTracker questionnaire, Patient Management system ED presentations and readmissions and contact with GPs.
Timepoint [1] 325165 0
30 days post caesarean section
Secondary outcome [1] 387053 0
The uptake of the Wound Health Questionnaire via HealthTracker: This outcome will be monitored by Healthtracker generated report


Timepoint [1] 387053 0
At the completion of the study
Secondary outcome [2] 387965 0
Acceptability of HealthTracker by response rates, enablers and barriers, including feedback from women with Aboriginal and culturally and linguistically diverse backgrounds by HealthTracker generated report and the feedback survey.
Timepoint [2] 387965 0
During the study period and at the completion of the study

Eligibility
Key inclusion criteria
All women giving birth to a live baby by CS at John Hunter Hospital over a 6-month period.
Minimum age
14 Years
Maximum age
No limit
Sex
Females
Can healthy volunteers participate?
No
Key exclusion criteria
Women with a stillbirth

Study design
Purpose of the study
Diagnosis
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Not applicable
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other
Other design features
The historical control data( baseline data) will be used to compare the SSI rates against the Post Intervention data.
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
The estimated number of eligible women in 6 months is 700 (CS rate: 34% of 4000 births annually). HealthTracker questionnaire data will be merged with hospital inpatient information systems data into a centralised data repository. Data analysis will include calculation of SSI rates. Differences in SSI rates between current surveillance methods and HealthTracker will be analysed. Descriptive statistics will be completed on the Acceptability Survey.

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
30/10/2020
Date of last participant enrolment
Anticipated
30/04/2021
Actual
Date of last data collection
Anticipated
10/05/2021
Actual
Sample size
Target
700
Accrual to date
44
Final
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 17553 0
John Hunter Hospital - New Lambton
Recruitment postcode(s) [1] 31288 0
2305 - New Lambton

Funding & Sponsors
Funding source category [1] 306770 0
Government body
Name [1] 306770 0
Hunter New England Local Health District Improvement Grant
Country [1] 306770 0
Australia
Primary sponsor type
Government body
Name
Hunter New England Local Health District Nursing and Midwifery Research Centre
Address
James Fletcher Campus, Gate Cottage, 72 Watt Street, Newcastle NSW 2300
Country
Australia
Secondary sponsor category [1] 307323 0
Government body
Name [1] 307323 0
John Hunter Hospital Maternity Service
Address [1] 307323 0
Lookout Road, Lambton Heights, NSW 2305
Country [1] 307323 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 306936 0
Hunter New England Local Health District Human Ethics Commitee
Ethics committee address [1] 306936 0
Ethics committee country [1] 306936 0
Australia
Date submitted for ethics approval [1] 306936 0
31/08/2020
Approval date [1] 306936 0
15/09/2020
Ethics approval number [1] 306936 0
2020/ETH02218

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 105506 0
A/Prof Michelle Giles
Address 105506 0
HNE Nursing and Midwifery Research Centre

James Fletcher Campus, Gate Cottage, 72 Watt Street, Newcastle NSW 2300
Country 105506 0
Australia
Phone 105506 0
+61 2 49246702
Fax 105506 0
Email 105506 0
michelle.giles@health.nsw.gov.au
Contact person for public queries
Name 105507 0
Michelle Giles
Address 105507 0
HNE Nursing and Midwifery Research Centre

James Fletcher Campus, Gate Cottage, 72 Watt Street, Newcastle NSW 2300
Country 105507 0
Australia
Phone 105507 0
+61 2 49246702
Fax 105507 0
Email 105507 0
michelle.giles@health.nsw.gov.au
Contact person for scientific queries
Name 105508 0
Michelle Giles
Address 105508 0
HNE Nursing and Midwifery Research Centre

James Fletcher Campus, Gate Cottage, 72 Watt Street, Newcastle NSW 2300
Country 105508 0
Australia
Phone 105508 0
+61 2 49246702
Fax 105508 0
Email 105508 0
michelle.giles@health.nsw.gov.au

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment
The information is health record information that can not be publically shared, therefore, the de-identified individual participant data will not be available for this study.

Any information will be de-identified at the report and publications.


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.